drugset / Trial / NCT02614534

Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma

NCT02614534

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma is effective in the treatment of locally advanced colorectal carcinoma.

Timeline

Start
2015-11-16
Primary completion
2024-03
Completion
2024-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitomycin C Other / unclassified 30 mg/m2 Other

Indications